These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 17295053)

  • 1. Attitudes toward fragile X mutation carrier testing from women identified in a general population survey.
    Anido A; Carlson LM; Sherman SL
    J Genet Couns; 2007 Feb; 16(1):97-104. PubMed ID: 17295053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Women's attitudes toward testing for fragile X carrier status: a qualitative analysis.
    Anido A; Carlson LM; Taft L; Sherman SL
    J Genet Couns; 2005 Aug; 14(4):295-306. PubMed ID: 16047092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of fragile X pre-mutation carriers in the Chinese obstetric population using a robust FMR1 polymerase chain reaction assay: implications for screening and prenatal diagnosis.
    Cheng YK; Lin CS; Kwok YK; Chan YM; Lau TK; Leung TY; Choy KW
    Hong Kong Med J; 2017 Apr; 23(2):110-6. PubMed ID: 28253484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence and instability of fragile X alleles: implications for offering fragile X prenatal diagnosis.
    Cronister A; Teicher J; Rohlfs EM; Donnenfeld A; Hallam S
    Obstet Gynecol; 2008 Mar; 111(3):596-601. PubMed ID: 18310361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. "It's something I need to consider": decisions about carrier screening for fragile X syndrome in a population of non-pregnant women.
    Archibald AD; Jaques AM; Wake S; Collins VR; Cohen J; Metcalfe SA
    Am J Med Genet A; 2009 Dec; 149A(12):2731-8. PubMed ID: 19938084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prenatal carrier testing for fragile X: counseling issues and challenges.
    Musci TJ; Moyer K
    Obstet Gynecol Clin North Am; 2010 Mar; 37(1):61-70, Table of Contents. PubMed ID: 20494258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The risk of fragile X premutation expansion is lower in carriers detected by general prenatal screening than in carriers from known fragile X families.
    Geva E; Yaron Y; Shomrat R; Ben-Yehuda A; Zabari S; Peretz H; Naiman T; Yeger H; Orr-Urtreger A
    Genet Test; 2000; 4(3):289-92. PubMed ID: 11142761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Longitudinal study of the carrier testing process for fragile X syndrome: perceptions and coping.
    McConkie-Rosell A; Spiridigliozzi GA; Sullivan JA; Dawson DV; Lachiewicz AM
    Am J Med Genet; 2001 Jan; 98(1):37-45. PubMed ID: 11426454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The FMR1 premutation and reproduction.
    Wittenberger MD; Hagerman RJ; Sherman SL; McConkie-Rosell A; Welt CK; Rebar RW; Corrigan EC; Simpson JL; Nelson LM
    Fertil Steril; 2007 Mar; 87(3):456-65. PubMed ID: 17074338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. "It's about having the choice": stakeholder perceptions of population-based genetic carrier screening for fragile X syndrome.
    Archibald AD; Hickerton CL; Jaques AM; Wake S; Cohen J; Metcalfe SA
    Am J Med Genet A; 2013 Jan; 161A(1):48-58. PubMed ID: 23239566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Newborn, carrier, and early childhood screening recommendations for fragile X.
    Abrams L; Cronister A; Brown WT; Tassone F; Sherman SL; Finucane B; McConkie-Rosell A; Hagerman R; Kaufmann WE; Picker J; Coffey S; Skinner D; Johnson V; Miller R; Berry-Kravis E
    Pediatrics; 2012 Dec; 130(6):1126-35. PubMed ID: 23129072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular predictors of cognitive involvement in female carriers of fragile X syndrome.
    Taylor AK; Safanda JF; Fall MZ; Quince C; Lang KA; Hull CE; Carpenter I; Staley LW; Hagerman RJ
    JAMA; 1994 Feb; 271(7):507-14. PubMed ID: 8301764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic dilemmas and genetic counseling for prenatally detected fragile X gene expansions.
    Finucane B; Lincoln S; Bailey L; Martin CL
    Prenat Diagn; 2017 Jan; 37(1):37-42. PubMed ID: 27862088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recommendations from multi-disciplinary focus groups on cascade testing and genetic counseling for fragile X-associated disorders.
    McConkie-Rosell A; Abrams L; Finucane B; Cronister A; Gane LW; Coffey SM; Sherman S; Nelson LM; Berry-Kravis E; Hessl D; Chiu S; Street N; Vatave A; Hagerman RJ
    J Genet Couns; 2007 Oct; 16(5):593-606. PubMed ID: 17497108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Benefits and burdens of genetic carrier identification.
    Williams JK; Schutte DL
    West J Nurs Res; 1997 Feb; 19(1):71-81. PubMed ID: 9030039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prenatal diagnosis and carrier screening for fragile X by PCR.
    Brown WT; Nolin S; Houck G; Ding X; Glicksman A; Li SY; Stark-Houck S; Brophy P; Duncan C; Dobkin C; Jenkins E
    Am J Med Genet; 1996 Jul; 64(1):191-5. PubMed ID: 8826474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular fragile X screening in normal populations.
    Spence WC; Black SH; Fallon L; Maddalena A; Cummings E; Menapace-Drew G; Bick DP; Levinson G; Schulman JD; Howard-Peebles PN
    Am J Med Genet; 1996 Jul; 64(1):181-3. PubMed ID: 8826471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characteristics of fragile X relatives with different attitudes toward terminating an affected pregnancy.
    Meryash DL
    Am J Ment Retard; 1992 Mar; 96(5):528-35. PubMed ID: 1562310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Premature ovarian failure (POF) and fragile X premutation females: from POF to to fragile X carrier identification, from fragile X carrier diagnosis to POF association data.
    Uzielli ML; Guarducci S; Lapi E; Cecconi A; Ricci U; Ricotti G; Biondi C; Scarselli B; Vieri F; Scarnato P; Gori F; Sereni A
    Am J Med Genet; 1999 May; 84(3):300-3. PubMed ID: 10331612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carrier testing in fragile X syndrome: when to tell and test.
    McConkie-Rosell A; Spiridigliozzi GA; Sullivan JA; Dawson DV; Lachiewicz AM
    Am J Med Genet; 2002 Jun; 110(1):36-44. PubMed ID: 12116269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.